Illumina (ILMN) Misses Revenue Forecast Causing Collateral Damage to Biotechs
Update-1 Biotechs Sinking Again ...IBB down 2.48%, ILMN down another 2% Related sequencing stocks: FMI down 1.75%, PACB flat at $8.40 Illumina (ILMN) Shares Crash on Revenue Miss Illumina (ILMN) shares crashed 25% to $139, after a warning on third quarter sales . The global leader in DNA...
Biotech Stocks Recovering from Last Week’s Free Fall: XBI…Update-2
Green Tape Today Shows Resilience-- 10/10/16 ESMO Cancer Congress 4%+ Up movers: AGIO ARIA BLUE CLVS LGND PBYI TSRO etc. XBI up 2.39% More Bad Clinical News for Biotech:ALNY,CLVS The XBI lost 3.2% for the week to $64.15 taking a hit from Alnylam (ALNY) downdraft down 49% for the week. The IBB...
Rayno 2016 Life Science Portfolio Update…BLUE,IBB…Update-2
Update-1... See Caution 9/29 Update-2...See Rayno Biobeat for updates after Trump Rally. For overweighting biotechs in a portfolio consider XBI instead of IBB to get mid and small cap exposure. -------- Rayno Portfolio Outperforms the Market Biotech stocks are near their intermediate highs but...
Biotech Stocks Pause at Resistance: IBB…Update-2…Caution
Update-2... 9/29 Caution on Biotech-Major Sell-Off with IBB off 3.12% The market had a bad day today hit by Wells Fargo (WFC) Congressional hearings and paranoia about Deutsche Bank AG (DB). Unrelated to this news was a major sell-off in biotech stocks with pricing concerns back in the news....
Biotech ETFs Lead Q3 Rally: XBI Breaks Out
Biotech ETFs Are Having A Strong Quarter and Offer Good Investment Options On July 20 we did a review of active funds vs biotech ETFs in the biotechnology/life science sector just after the BREXIT lows. At that time biotech ETFs and broadly diversified funds beat the "pure play" biotechnology...